FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1001000221103: Vaccine product containing only inactivated whole Vibrio cholerae antigen in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3947048017 Inactivated cholera vaccine in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3973828019 Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3973829010 Vaccine product containing only inactivated whole Vibrio cholerae antigen in oral dose form (medicinal product form) en Fully specified name Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form Is a Vibrio cholerae antigen only vaccine product in oral dose form true Inferred relationship Some
Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Some
Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form Plays role Active immunity stimulant role (role) true Inferred relationship Some
Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form Has active ingredient Antigen of inactivated whole Vibrio cholerae (substance) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start